Third Harmonic Bio, Inc. – NASDAQ:THRD

Third Harmonic Bio stock price today

$5.38
-4.88
-47.56%
Financial Health
0
1
2
3
4
5
6
7
8
9

Third Harmonic Bio stock price monthly change

-20.95%
month

Third Harmonic Bio stock price quarterly change

-20.95%
quarter

Third Harmonic Bio stock price yearly change

-10.55%
year

Third Harmonic Bio key metrics

Market Cap
471.31M
Enterprise value
N/A
P/E
-1.66
EV/Sales
N/A
EV/EBITDA
-8.06
Price/Sales
N/A
Price/Book
0.20
PEG ratio
N/A
EPS
-0.37
Revenue
N/A
EBITDA
-21.53M
Income
-14.90M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Third Harmonic Bio stock price history

Third Harmonic Bio stock forecast

Third Harmonic Bio financial statements

Third Harmonic Bio, Inc. (NASDAQ:THRD): Profit margin
Jun 2023 0 -7.56M
Sep 2023 0 7.34M
Dec 2023 836K -6.83M -817.7%
Mar 2024 0 -7.85M
Third Harmonic Bio, Inc. (NASDAQ:THRD): Analyst Estimates
Dec 2023 836K -6.83M -817.7%
Mar 2024 0 -7.85M
Oct 2025 0 -10.45M
Dec 2025 0 -12.86M
  • Analysts Price target

  • Financials & Ratios estimates

Third Harmonic Bio, Inc. (NASDAQ:THRD): Earnings per share (EPS)
2023-11-09 -0.39 -0.19
2024-03-26 -0.33 0.17
2024-05-15 -0.33 -0.2
Third Harmonic Bio, Inc. (NASDAQ:THRD): Debt to assets
Jun 2023 285822000 7.81M 2.73%
Sep 2023 282250000 9.29M 3.29%
Dec 2023 277711000 8.62M 3.11%
Mar 2024 270521000 7.02M 2.59%
Third Harmonic Bio, Inc. (NASDAQ:THRD): Cash Flow
Jun 2023 -3.96M -168K 58K
Sep 2023 -4.18M 0 -57K
Dec 2023 -5.60M -1K 798K
Mar 2024 -6.29M 0 49K

Third Harmonic Bio alternative data

Third Harmonic Bio, Inc. (NASDAQ:THRD): Employee count
Aug 2023 28
Sep 2023 31
Oct 2023 31
Nov 2023 31
Dec 2023 32
Jan 2024 32
Feb 2024 32
Mar 2024 30
Apr 2024 30
May 2024 30
Jun 2024 31
Jul 2024 31

Third Harmonic Bio other data

36.81% -63.19%
of THRD is owned by hedge funds
4.94M -30.67M
shares is hold by hedge funds

Third Harmonic Bio, Inc. (NASDAQ:THRD): Insider trades (number of shares)
Period Buy Sel
Dec 2023 0 17653
Apr 2024 0 14665
May 2024 0 44842
Jun 2024 0 10494
Transaction Date Insider Security Shares Price per share Total value Source
Option
PERSON JULIE officer: CHIEF ADMINISTRATIVE O..
Employee Option Grant (right to buy) 10,000 $4.2 $42,000
Option
PERSON JULIE officer: CHIEF ADMINISTRATIVE O..
Common Stock 10,000 $4.2 $42,000
Sale
PERSON JULIE officer: CHIEF ADMINISTRATIVE O..
Common Stock 10,000 $12.46 $124,570
Option
DITTMAN JENNIFER officer: Chief Development Oper..
Employee Stock Option (right to buy) 494 $4.2 $2,075
Sale
DITTMAN JENNIFER officer: Chief Development Oper..
Common Stock 494 $14.17 $7,000
Option
DITTMAN JENNIFER officer: Chief Development Oper..
Employee Stock Option (right to buy) 1,042 $4.3 $4,481
Sale
DITTMAN JENNIFER officer: Chief Development Oper..
Common Stock 1,042 $14 $14,588
Option
DITTMAN JENNIFER officer: Chief Development Oper..
Employee Stock Option (right to buy) 16,666 $4.3 $71,664
Sale
DITTMAN JENNIFER officer: Chief Development Oper..
Common Stock 23,578 $14.04 $331,059
Option
DITTMAN JENNIFER officer: Chief Development Oper..
Employee Stock Option (right to buy) 6,912 $4.2 $29,030
Monday, 25 November 2024
globenewswire.com
Monday, 11 November 2024
zacks.com
Thursday, 7 November 2024
globenewswire.com
globenewswire.com
Tuesday, 10 September 2024
globenewswire.com
Monday, 26 August 2024
globenewswire.com
Thursday, 8 August 2024
globenewswire.com
Tuesday, 28 May 2024
globenewswire.com
Wednesday, 15 May 2024
globenewswire.com
Thursday, 28 March 2024
globenewswire.com
Tuesday, 26 March 2024
globenewswire.com
Monday, 26 February 2024
globenewswire.com
Thursday, 22 February 2024
prnewswire.com
Thursday, 4 January 2024
globenewswire.com
Friday, 29 December 2023
Zacks Investment Research
Thursday, 31 August 2023
GlobeNewsWire
Friday, 3 February 2023
Benzinga
Tuesday, 10 January 2023
Benzinga
Thursday, 15 December 2022
InvestorPlace
Market Watch
  • What's the price of Third Harmonic Bio stock today?

    One share of Third Harmonic Bio stock can currently be purchased for approximately $5.38.

  • When is Third Harmonic Bio's next earnings date?

    Unfortunately, Third Harmonic Bio's (THRD) next earnings date is currently unknown.

  • Does Third Harmonic Bio pay dividends?

    No, Third Harmonic Bio does not pay dividends.

  • How much money does Third Harmonic Bio make?

    Third Harmonic Bio has a market capitalization of 471.31M. Third Harmonic Bio made a loss 30.82M US dollars in net income (profit) last year or -$0.2 on an earnings per share basis.

  • What is Third Harmonic Bio's stock symbol?

    Third Harmonic Bio, Inc. is traded on the NASDAQ under the ticker symbol "THRD".

  • What is Third Harmonic Bio's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Third Harmonic Bio?

    Shares of Third Harmonic Bio can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Third Harmonic Bio have?

    As Jul 2024, Third Harmonic Bio employs 31 workers, which is 3% more then previous quarter.

  • When Third Harmonic Bio went public?

    Third Harmonic Bio, Inc. is publicly traded company for more then 2 years since IPO on 14 Sep 2022.

  • What is Third Harmonic Bio's official website?

    The official website for Third Harmonic Bio is thirdharmonicbio.com.

  • Where are Third Harmonic Bio's headquarters?

    Third Harmonic Bio is headquartered at 300 Technology Square, Cambridge, MA.

  • How can i contact Third Harmonic Bio?

    Third Harmonic Bio's mailing address is 300 Technology Square, Cambridge, MA and company can be reached via phone at +61 79156680.

Third Harmonic Bio company profile:

Third Harmonic Bio, Inc.

thirdharmonicbio.com
Exchange:

NASDAQ

Full time employees:

51

Industry:

Biotechnology

Sector:

Healthcare

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.

300 Technology Square
Cambridge, MA 02139

CIK: 0001923840
ISIN: US88427A1079
CUSIP: 88427A107